These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 2775311)
1. New photoaffinity labels for rat brain muscarinic acetylcholine receptors. Ilien B; Mejean A; Hirth C Biochem Pharmacol; 1989 Sep; 38(17):2879-87. PubMed ID: 2775311 [TBL] [Abstract][Full Text] [Related]
2. Direct and energy-transfer photolabelling of brain muscarinic acetylcholine receptors. Ilien B; Hirth C Eur J Biochem; 1989 Aug; 183(2):331-7. PubMed ID: 2759087 [TBL] [Abstract][Full Text] [Related]
3. Covalent labeling of muscarinic acetylcholine receptors by tritiated aryldiazonium photoprobes. Autelitano F; Weill C; Goeldner M; Ilien B Biochem Pharmacol; 1997 Feb; 53(4):501-10. PubMed ID: 9105401 [TBL] [Abstract][Full Text] [Related]
4. Aryldiazonium salts as photoaffinity labels of the nicotinic acetylcholine receptor PCP binding site. Kotzyba-Hibert F; Lagenbuch-Cachat J; Jaganathen J; Goeldner M; Hirth C FEBS Lett; 1985 Mar; 182(2):297-301. PubMed ID: 3979552 [TBL] [Abstract][Full Text] [Related]
5. Aryl diazo compounds and diazonium salts as potential irreversible probes of the gamma-aminobutyric acid receptor. Bouchet MJ; Rendon A; Wermuth CG; Goeldner M; Hirth C J Med Chem; 1987 Dec; 30(12):2222-7. PubMed ID: 2824775 [TBL] [Abstract][Full Text] [Related]
6. Affinity labeling of muscarinic receptors in rat cerebral cortex with a photolabile antagonist. Amitai G; Avissar S; Balderman D; Sokolovsky M Proc Natl Acad Sci U S A; 1982 Jan; 79(2):243-7. PubMed ID: 6952181 [TBL] [Abstract][Full Text] [Related]
7. Effects of in vivo and in vitro treatments with N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on putative muscarinic receptor subtypes in rat brain. Norman AB; Creese I Mol Pharmacol; 1986 Aug; 30(2):96-103. PubMed ID: 3755499 [TBL] [Abstract][Full Text] [Related]
8. Affinity ligands and related agents for brain muscarinic and nicotinic cholinergic receptors. Abood LG; Saraswati M; Lerner-Marmarosh N; Hashmi M Biochem Pharmacol; 1993 May; 45(10):2143-8. PubMed ID: 8512596 [TBL] [Abstract][Full Text] [Related]
9. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes. Burke RE Mol Pharmacol; 1986 Jul; 30(1):58-68. PubMed ID: 3755217 [TBL] [Abstract][Full Text] [Related]
10. Photoaffinity labeling of the solubilized, partially purified muscarinic acetylcholine receptor from porcine atria by p-azidoatropine methyl iodide. Cremo C; Schimerlik MI Biochemistry; 1984 Jul; 23(15):3494-501. PubMed ID: 6547852 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of 2-diazo-3,3,3-trifluopropanoyl derivatives of colchicine and podophyllotoxin as photoaffinity labels: reactivity, photochemistry, and tubulin binding. Hahn KM; Hastie SB; Sundberg RJ Photochem Photobiol; 1992 Jan; 55(1):17-27. PubMed ID: 1603847 [TBL] [Abstract][Full Text] [Related]
12. Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists. Gillard M; Waelbroeck M; Christophe J Mol Pharmacol; 1987 Jul; 32(1):100-8. PubMed ID: 3600611 [TBL] [Abstract][Full Text] [Related]
13. Comparative ontogenic profile of cholinergic markers, including nicotinic and muscarinic receptors, in the rat brain. Aubert I; Cécyre D; Gauthier S; Quirion R J Comp Neurol; 1996 May; 369(1):31-55. PubMed ID: 8723701 [TBL] [Abstract][Full Text] [Related]
14. Heterogeneity of binding sites on cardiac muscarinic receptors induced by the neuromuscular blocking agents gallamine and pancuronium. Dunlap J; Brown JH Mol Pharmacol; 1983 Jul; 24(1):15-22. PubMed ID: 6135150 [TBL] [Abstract][Full Text] [Related]
15. Multiple binding affinities of N-methylscopolamine to brain muscarinic acetylcholine receptors: differentiation from M1 and M2 receptor subtypes. el-Fakahany EE; Ramkumar V; Lai WS J Pharmacol Exp Ther; 1986 Aug; 238(2):554-63. PubMed ID: 3755473 [TBL] [Abstract][Full Text] [Related]
16. 3-Diazirine-derivatives of bile salts for photoaffinity labeling. Kramer W; Schneider S J Lipid Res; 1989 Aug; 30(8):1281-8. PubMed ID: 2769079 [TBL] [Abstract][Full Text] [Related]
17. Photoactivatable agonist of the nicotinic acetylcholine receptor: potential probe to characterize the structural transitions of the acetylcholine binding site in different states of the receptor. Chatrenet B; Kotzba-Hibert F; Mulle C; Changeux JP; Goeldner MP; Hirth C Mol Pharmacol; 1992 Jun; 41(6):1100-6. PubMed ID: 1614412 [TBL] [Abstract][Full Text] [Related]
18. L-689,660, a novel cholinomimetic with functional selectivity for M1 and M3 muscarinic receptors. Hargreaves RJ; McKnight AT; Scholey K; Newberry NR; Street LJ; Hutson PH; Semark JE; Harley EA; Patel S; Freedman SB Br J Pharmacol; 1992 Oct; 107(2):494-501. PubMed ID: 1422595 [TBL] [Abstract][Full Text] [Related]
19. Interaction of anandamide with the M(1) and M(4) muscarinic acetylcholine receptors. Christopoulos A; Wilson K Brain Res; 2001 Oct; 915(1):70-8. PubMed ID: 11578621 [TBL] [Abstract][Full Text] [Related]
20. Oligomeric structure of muscarinic receptors is shown by photoaffinity labeling: subunit assembly may explain high- and low-affinity agonist states. Avissar S; Amitai G; Sokolovsky M Proc Natl Acad Sci U S A; 1983 Jan; 80(1):156-9. PubMed ID: 6571990 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]